Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Shay Shemesh Insider Profile

4 Followers

Shay Shemesh, Chief Dev. & Ops. Officer at Nuvectis Pharma, holds 1.79M shares in Nuvectis Pharma (Ticker: NVCT).

Shay Shemesh's Trading History

NVCTNuvectis Pharma		Jan 09, 2026Chief Dev. & Ops. OfficerUninformative Buy―$33.14M
NVCT
Insider Shares: 1.79M (7.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 09, 2026Uninformative Buy$0.00150,000$0.00―
Jan 03, 2025Uninformative Buy$0.00150,000$0.00―
May 13, 2024Informative Buy$7.03K1,113$6.32+32.70%
Jan 05, 2024Uninformative Buy$0.00130,000$0.00―
Mar 22, 2023Informative Buy$5.04K420$11.99-26.40%
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Shay Shemesh insider profile FAQ

What is the percentage of profitable transactions made by Shay Shemesh?
The percentage of profitable transactions made by Shay Shemesh is 67%.
What is the average return per transaction made by Shay Shemesh?
The average return per transaction made by Shay Shemesh is 26.50%.
What stocks does Shay Shemesh hold?
Shay Shemesh holds: NVCT stocks.
What was Shay Shemesh's most profitable transaction?
Shay Shemesh’s most profitable transaction was an Informative Buy of NVCT stock on September 27, 2022. The return on the trade was 87.40%.
What is Shay Shemesh's role in Nuvectis Pharma?
Shay Shemesh's role in Nuvectis Pharma is Chief Dev. & Ops. Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.